|
Quotes & Info
|
| ALXA > SEC Filings for ALXA > Form 8-K on 1-Aug-2012 | All Recent SEC Filings |
1-Aug-2012
Other Events, Financial Statements and Exhibits
On August 1, 2012, Alexza Pharmaceuticals, Inc. announced management promotions of James V. Cassella, Ph.D. as Executive Vice President, Research and Development, and Chief Scientific Officer, Darl Moreland as Senior Vice President, Quality, Mark K. Oki as Senior Vice President, Finance and Chief Financial Officer, and Ed Kamemoto, Ph.D. as Vice President, Regulatory Affairs. The press release is furnished as Exhibit 99.1 hereto, the contents of which are incorporated herein by reference.
(d) Exhibits.
Exhibit Number Description
99.1 Press Release titled "Alexza Announces Management
Promotions," dated August 1, 2012.
|
|
|